Small Pharma Inc (DMT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 02/28
| 02-2022 | 11-2021 | 08-2021 | 05-2021 | 02-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 5 | 5 | 5 | 5 | 4 |
| Accounts receivable | -851 | -4 | 252 | -161 | 474 |
| Other Working Capital | -461 | 925 | 1,349 | -297 | 210 |
| Other Operating Activity | -3,812 | -4,461 | -4,399 | -4,335 | -2,492 |
| Operating Cash Flow | $-5,118 | $-3,535 | $-2,792 | $-4,789 | $-1,804 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | N/A | N/A | N/A | -57 |
| Net Acquisitions | 0 | 0 | 0 | 109 | N/A |
| Other Investing Activity | 0 | -6 | -2 | -2,500 | 0 |
| Investing Cash Flow | $-5 | $-6 | $-2 | $-2,391 | $-57 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 6,366 |
| Common Stock Issued | 47 | -4,248 | -42 | 58,042 | 0 |
| Other Financing Activity | 31 | 4,248 | -192 | -3,995 | 0 |
| Financing Cash Flow | $78 | $0 | $-234 | $54,047 | $6,366 |
| Exchange Rate Effect | 77 | -1,122 | 542 | 129 | 403 |
| Beginning Cash Position | 45,624 | 50,287 | 52,774 | 5,778 | 870 |
| End Cash Position | 40,656 | 45,624 | 50,287 | 52,774 | 5,778 |
| Net Cash Flow | $-5,044 | $-3,542 | $-3,029 | $46,867 | $4,505 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,118 | -3,535 | -2,792 | -4,789 | -1,804 |
| Capital Expenditure | -5 | N/A | N/A | N/A | -57 |
| Free Cash Flow | -5,123 | -3,535 | -2,792 | -4,789 | -1,862 |